|
Steven J. Martin, Pharm.D., BCPS, FCCP, FCCM Professor and Chairman 419-530-1964 |
|
Dr. Martin graduated from Ferris State University in 1983 with a BS in Pharmacy, and in 1992 from Ferris with the Doctor of Pharmacy degree. He completed post-doctoral fellowship training in critical care and infectious diseases pharmacotherapy at The University of Illinois at Chicago (UIC). Dr. Martin continued on faculty at UIC until moving to The University of Toledo in 1997. He was promoted to Associate Professor with tenure in 2002, and has served as the Interim Department Chairman since December 2004. He also holds a faculty appointment in the College of Medicine.
Dr. Martin is a Board Certified Pharmacotherapy Specialist with Added Qualifications in Infectious Diseases, a distinction he has held since 1994. He was elected a Fellow in the American College of Critical Care Medicine in 2002, and a Fellow in the American College of Clinical Pharmacy in 2004. Dr. Martin has served in leadership positions in the Society of Critical Care Medicine, and currently is an elected pharmacist representative to the Society’s governing Council.
Dr. Martin has practiced pharmacy in the critical care setting since 1985, and his research focus is on infection in the critically ill. Dr. Martin also directs an infectious disease/critical care pharmacy fellowship program at UT, and established specialty and general practice residency programs at UT in conjunction with faculty from the University of Toledo Medical Center. He is the Co-Director of The Infectious Disease Research laboratory in the College of Pharmacy. Dr. Martin has published numerous books, book chapters, research papers, and critical reviews on infection and critical illness in a variety of peer-reviewed publications. He recently served as Editor of the Injectable Drug Reference, published by The Society of Critical Care Medicine.
Dr. Martin is a Michigan native, a third generation pharmacist, and a third generation Ferris graduate. He and his wife, Karen, have four children, including a daughter enrolled at UT.
RECENT PUBLICATIONS (2000-2009)
Pharmacotherapy in Critical Illness; April 2006; Martin SJ, Dasta JF guest editors.
Critical Care Clinics of North America
The Injectable Drug Reference, second edition 2006; Martin SJ editor; Society of Critical Care Medicine
Martin, SJ, Estrada SJ. Contemporary Issues and Novel Strategies To Manage Infections in the Critically Ill. In Ed: Chant, C. Pharmacotherapy Self-Assessment Program, 5th ed. Infectious Diseases. Kansas City, MO: American College of Clinical Pharmacy, 2010: In Press
Martin SJ , Jung R. Gastrointestinal Infections And Enterotoxigenic Poisonings. In Eds. Dipiro JT et al. Pharmacotherapy; Seventh edition, McGraw-Hill, New York, NY. McGraw-Hill, NY 2008
Martin SJ, Sahloff ES. Laboratory Tests in Infectious Diseases. In: Ed. Swinghammer TL. Pharmacotherapy; A Patient-Focused Approach. Seventh edition, Appleton & Lange, Stamford, CT. 2008
Martin SJ , Jung R. Gastrointestinal Infections And Enterotoxigenic Poisonings. In Eds. Dipiro JT et al. Pharmacotherapy: A Pathophysiologic Approach. Sixth edition, McGraw-Hill, New York, NY. 2005
Martin SJ. Beta-lactam and Related Antibiotics. In Ed. Fink MP, Abraham E, Kochanek PM, Vincent J-L. Textbook of Critical Care, WB Saunders, Philadelphia, PA, 2005
Martin SJ, Ohlinger MJ. Nosocomial Gram-Negative Infections. In: Shumock G. Brundage D, Chapman M, et al. es. Pharmacotherapy Self-Assessment Program, 5th ed. Infectious Diseases. Kansas City, MO: American College of Clinical Pharmacy, 2005: 235-256
Sahloff EG, Martin SJ. Clostridium difficile-Associated Diarrhea. In Ed. Swinghammer TL. Pharmacotherapy; A Patient-Focused Approach. Sixth edition, Appleton & Lange, Stamford, CT 2005
Martin SJ, Sahloff EG. Laboratory Tests in Infectious Diseases. In: Ed. Swinghammer TL. Pharmacotherapy; A Patient-Focused Approach. Sixth edition, Appleton & Lange, Stamford, CT 2005
Close SJ, Martin SJ. Sepsis. In Ed. Swinghammer TL. Pharmacotherapy; A Patient-Focused Approach. Sixth edition, Appleton & Lange, Stamford, CT 2005
Sahloff EG, Martin SJ. Clostridium difficile-Associated Diarrhea. In Ed. Swinghammer TL. Pharmacotherapy; A Patient-Focused Approach. Fifth edition, Appleton & Lange, Stamford, CT 2002 pp.309-311
Martin SJ, Sahloff EG. Laboratory Tests in Infectious Diseases. In: Ed. Swinghammer TL. Pharmacotherapy; A Patient-Focused Approach. Fifth edition, Appleton & Lange, Stamford, CT 2002 pp. 285-287
Martin SJ. Therapeutic Perspectives and Applications for the Newer Fluoroquinolones. In Ed. Jauregui L. Manual Practico de use de Antimicrobianos, 2001
Martin SJ. Using Laboratory Tests in Infectious Diseases. In: Ed. Swinghammer TL. Pharmacotherapy; A Patient-Focused Approach. Second edition, Appleton & Lange, Stamford, CT 2000 p.235
Smith KM, Scott DR, Barner JC, Dehart RM, Scott JD, Martin SJ. Interprofessional education in six US colleges of pharmacy. : Am J Pharm Educ. 2009 Jul 10;73(4):61
MacLaren R, Bond. C, Martin SJ, Fike, D. Clinical and Economic Outcomes of Involving Pharmacists in the Direct Care of Critically Ill Patients with Infections. In Press (November 2008 Publication Date), Critical Care Medicine
MacLaren R, Devlin J, Martin S, Dasta J, Rudis M, Bond C. Critical care pharmacy services in United States Hospitals. Annals of Pharmacotherapy 2006; 40: 612-618
Huang B, Martin SJ, Bachmann K, He X, Reese J, Wei Y, Iwuagwu C. A nationwide survey of physician office visits found that inappropriate antibiotic prescriptions were issued for bacterial respiratory tract infections in ambulatory patients. Journal of Clinical Epidemiology 2005; 58: 414-420
Erstad BL, Martin SJ, Brophy GM, Haas CE, Jacobi J, Welage LS, Thomas MC. Key articles and guidelines relative to intensive care unit pharmacology-2004. Pharmacotherapy 2005; 25: 585-610
Martin SJ, Zeigler DG. The use of the fluoroquinolones in the treatment of skin infections. Invited submission to Expert Opinion in Pharmacotherapy, 2004; 5: 237-246
Martin SJ, Close SJ. Fluoroquinolone-associated length of stay reduction in the hospital treatment of community-acquired pneumonia. Infectious Disease in Clinical Practice 2003; 11: 540-549
Jung R, Pendland SL, Martin SJ. The effect of perfluorooctyl bromide on bacterial growth. Chemotherapy 2003; 49: 1-7
Tesoro EP, Jung R, Messick CR, Martin SJ, Pendland SL. In vitro evaluation of antibiotic combinations against hospital-acquired isolates of Stenotrophomonas (Xanthomonas) maltophilia. Journal of Applied Research, 2003;3(2) http://www.jrnlappliedresearch.com/articles/Vol3Iss2/Pendland.htm
Olsen KM, Martin SJ. Pharmacokinetics and clinical use of drotrecogin alfa (activated) in patients with severe sepsis. Pharmacotherapy. 2002 Dec;22(12 Pt 2):196S-205S
Jung R, Pendland SL, Martin SJ. Combined Bactericidal Activity of Perfluorooctyl bromide and Aminoglycosides against Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy 2002; 50: 939-944.
Close SJ, McBurney CR, Garvin CG, Chen DC, Martin SJ. Trimethoprim-sulfamthoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus. Pharmacotherapy 2002; 22: 983-989
Martin SJ, Sahloff EG, Close SJ. Evaluation and cost assessment of fluoroquinolones in community acquired respiratory infections. Expert Opinion on Pharmacotherapy 2002; 3: 1251-1266
Sahloff EG, Martin SJ. Extended-spectrum b-lactamase resistance in the ICU. Journal of Pharmacy Practice 2002; 15: 96-105
Sahloff EG, Smith BP, Martin SJ. E-testing for the determination of MICs for selected fluoroquinolones against Pseudomonas aeruginosa and Streptococcus pneumoniae. Journal of Pharmacy Technology 2002: 18: 241-247
Martin SJ, Jung R, Garvin CG.A risk-benefit analysis of Levofloxacin in respiratory, skin and skin-structure, and urinary tract infections. Drug Safety 2001; 24(3): 1-24
Martin SJ, Garvin CG, McBurney CR, Sahloff G. The activity of 14-hydroxy clarithromycin, alone and in combination with clarithromycin against penicillin- and erythromycin-resistant Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy, 2001; 3: 156-160
NON-PEER REVIEWED
Sanuth B, Ohlinger, MJ, Martin SJ. Ceftobiprole and doriepenem: New antibiotics for potential use in critical illness. Critical Connections 2009; 8(3)18-19
Kollef MH, Martin SJ, Lipsitt, PA. Fighting the never ending battle against antimicrobial resistance. Critical Connections 2008; June: 11-13.
Martin SJ, Moran MC. Contemporary antimicrobial focus in critical illness: MRSA and Fungi. Critical Connections 2006; 5(2): 6-7
Martin SJ. Drotrecogin alfa (activated): Safety and efficacy. U.S. Pharmacist 2003; August Supplement: 7-11
Sibbald WJ, Martin SJ. Blood substitutes and erythropoietic stimulants. In Proceedings of the Mid American Critical Care Symposium; supplement to Pharmacy Practice News, November 2002: S2-S4
Pruchnicki M, Martin SJ. Renal protection: show me the evidence. In Proceedings of the Mid American Critical Care Symposium; supplement to Pharmacy Practice News, November 2002: S16-S19
